INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 423m ago
HOUSE PTR23m ago
SEC 13F23m ago
ROBINHOOD CHAIN23m ago
Corporate insider
SC

Smith Nicholas Conrad

CHIEF FINANCIAL OFFICER & CBOCIK 0002009130

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 3
Max Insider Score42
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M$128K
55.0K sh
Oct 2, 2026Oct 5, 2026
traded Oct 2, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Alto Neuroscience, Inc.CHIEF FINANCIAL OFFICER & CBO · Feb 13, 2026
17
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M
—
55.0K sh
Oct 2, 2026
Oct 5, 2026
traded Oct 2, 2026
+3d
SEC FORM 4

Evidence

9
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M—
54.4K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

13
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M—
24.1K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

17
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Open-market sale
SELL$24K
886 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

20
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M$57K
24.1K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

24
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M$133K
56.5K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

24
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M$128K
54.4K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

42
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Open-market sale
SELL$2.95M
110.8K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

31
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Open-market sale
SELL$597K
23.2K sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

21
SC
Smith Nicholas ConradPRESIDENT AND CFO
ANROAlto Neuroscience, Inc.
Option exercise
M—
56.5K sh
Sep 29, 2026Oct 1, 2026
traded Sep 29, 2026
+2dSEC FORM 4

Evidence

9
SC
Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO
ANROAlto Neuroscience, Inc.
Grant or award
A—
200.0K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence